The Babraham Institute is a world-class research institution, housed at the heart of the Babraham Research Campus, focused upon understanding the biological mechanisms underpinning lifelong health and wellbeing. Our 28 research laboratories are grouped into four programmes: Signalling, Lymphocyte Signalling and Development, Epigenetics and Nuclear Dynamics, funded by four Institute Strategic Programme Grants (ISPGs) awarded by the BBSRC. Additional response mode grant funding from the BBSRC, MRC, Wellcome Trust, other charities, EU and industry supports uplift from these core research programmes.
The Institute’s scientists are housed in modern research buildings and we benefit from the provision of outstanding core facilities through funding by the BBSRC, these include imaging, flow cytometry, next generation sequencing, mass spectrometry and small animal facilities. These capabilities assist in ensuring that Babraham’s research remains cutting edge and are highlighted within this web site.
The Institute has a tradition of sustained innovation in the areas of lipid and calcium signalling, in immunology and in genetics. Over the past 20 years this has resulted in significant advances in, for example, understanding of the role and regulation of PI-3-kinase signalling and in the unravelling of the role, nature and mechanism of epigenetic change. These, and other advances, have not just generated significant publications, but have also promoted translation of our research.
Professor Michael Wakelam